Kumar Neil
Insider CIK 1742485 · EIDX Chief Executive Officer, Director, 10% owner · BBIO See Remarks, Director · MAZE Director · BBOT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 8,721 | $69.01 | $601.8K | 496,965 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 1,279 | $69.57 | $89.0K | 495,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 1,279 | $69.57 | $89.0K | 495,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 8,721 | $69.01 | $601.9K | 496,965 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 8,100 | $83.86 | $679.3K | 507,586 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 1,800 | $84.69 | $152.4K | 505,786 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 100 | $85.65 | $8.6K | 505,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 100 | $85.65 | $8.6K | 505,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 1,800 | $84.69 | $152.4K | 505,786 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 8,100 | $83.86 | $679.3K | 507,586 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 1,199 | $83.77 | $100.4K | 243,327 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 17,279 | $82.21 | $1.42M | 259,128 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 1,900 | $81.15 | $154.2K | 276,407 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 14,602 | $82.99 | $1.21M | 244,526 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 1,199 | $83.77 | $100.4K | 243,327 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 14,602 | $82.99 | $1.21M | 244,526 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 17,279 | $82.21 | $1.42M | 259,128 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 1,900 | $81.15 | $154.2K | 276,407 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-08-16 | 2026-08-18 | 33,544 | — | $0 | 67,088 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-08-16 | 2026-08-18 | 11,554 | — | $0 | 115,538 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-08-16 | 2026-08-18 | 6,520 | — | $0 | 91,274 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-08-16 | 2026-08-18 | 19,599 | — | $0 | 117,596 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-08-16 | 2026-08-18 | 11,554 | — | $0 | 308,024 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-08-16 | 2026-08-18 | 33,544 | — | $0 | 276,871 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-08-16 | 2026-08-18 | 19,599 | — | $0 | 296,470 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-08-16 | 2026-08-18 | 6,520 | — | $0 | 314,544 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2026-08-16 | 2026-08-18 | 36,237 | $79.86 | $2.89M | 278,307 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-08-16 | 2026-08-18 | 6,520 | — | $0 | 91,274 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-08-16 | 2026-08-18 | 11,554 | — | $0 | 115,538 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-08-16 | 2026-08-18 | 19,599 | — | $0 | 117,596 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-08-16 | 2026-08-18 | 33,544 | — | $0 | 67,088 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2026-08-16 | 2026-08-18 | 36,237 | $79.86 | $2.89M | 278,307 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-08-16 | 2026-08-18 | 6,520 | — | — | 314,544 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-08-16 | 2026-08-18 | 11,554 | — | — | 308,024 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-08-16 | 2026-08-18 | 19,599 | — | — | 296,470 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-08-16 | 2026-08-18 | 33,544 | — | — | 276,871 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award deriv | 2026-06-16 | 2026-06-18 | 31,675 | — | $0 | 31,675 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-05 | 2026-06-08 | 7,148 | $67.20 | $480.3K | 4,331,299 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-05 | 2026-06-08 | 8,437 | $67.88 | $572.7K | 4,322,862 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-05 | 2026-06-08 | 8,437 | $67.88 | $572.7K | 520,102 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-05 | 2026-06-08 | 4,416 | $68.96 | $304.5K | 515,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-05 | 2026-06-08 | 4,415 | $68.96 | $304.5K | 4,318,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-05 | 2026-06-08 | 7,147 | $67.20 | $480.3K | 528,539 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-04 | 2026-06-08 | 450 | $68.27 | $30.7K | 4,338,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-04 | 2026-06-08 | 15,921 | $67.74 | $1.08M | 4,338,897 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-04 | 2026-06-08 | 1,429 | $66.72 | $95.3K | 4,354,818 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-04 | 2026-06-08 | 2,200 | $65.72 | $144.6K | 4,356,247 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-04 | 2026-06-08 | 450 | $68.27 | $30.7K | 535,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-04 | 2026-06-08 | 15,921 | $67.74 | $1.08M | 536,136 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-04 | 2026-06-08 | 1,429 | $66.72 | $95.3K | 552,057 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-04 | 2026-06-08 | 2,200 | $65.72 | $144.6K | 553,486 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-21 | 2026-05-26 | 11,250 | $70.48 | $792.9K | 244,127 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-21 | 2026-05-26 | 5,072 | $69.22 | $351.1K | 255,377 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-21 | 2026-05-26 | 6,725 | $68.30 | $459.3K | 260,449 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-21 | 2026-05-26 | 2,256 | $67.57 | $152.4K | 267,174 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-21 | 2026-05-26 | 800 | $70.92 | $56.7K | 243,327 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-05-16 | 2026-05-19 | 19,599 | — | $0 | 137,195 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-05-16 | 2026-05-19 | 11,553 | — | $0 | 127,092 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-05-16 | 2026-05-19 | 33,544 | — | $0 | 100,632 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-05-16 | 2026-05-19 | 6,519 | — | $0 | 97,794 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-05-16 | 2026-05-19 | 11,553 | — | $0 | 299,147 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-05-16 | 2026-05-19 | 6,519 | — | $0 | 305,666 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2026-05-16 | 2026-05-19 | 36,236 | $66.13 | $2.40M | 269,430 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-05-16 | 2026-05-19 | 19,599 | — | $0 | 287,594 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-05-16 | 2026-05-19 | 33,544 | — | $0 | 267,995 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-08 | 2026-05-11 | 950 | $68.35 | $64.9K | 4,358,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-08 | 2026-05-11 | 5,076 | $67.35 | $341.9K | 4,359,397 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-08 | 2026-05-11 | 13,974 | $66.65 | $931.4K | 4,364,473 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-08 | 2026-05-11 | 950 | $68.35 | $64.9K | 555,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-08 | 2026-05-11 | 5,077 | $67.35 | $341.9K | 556,636 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-08 | 2026-05-11 | 13,973 | $66.65 | $931.3K | 561,713 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 449 | $69.09 | $31.0K | 4,378,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 11,217 | $67.50 | $757.1K | 584,469 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 8,334 | $68.38 | $569.9K | 4,378,896 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 11,217 | $67.49 | $757.0K | 4,387,230 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 450 | $69.09 | $31.1K | 575,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 8,333 | $68.38 | $569.8K | 576,136 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-04-10 | 2026-04-13 | 20,000 | $74.60 | $1.49M | 595,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-04-10 | 2026-04-13 | 20,000 | $74.60 | $1.49M | 4,398,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-04-09 | 2026-04-13 | 5,300 | $74.60 | $395.4K | 623,186 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-04-09 | 2026-04-13 | 7,500 | $75.55 | $566.6K | 615,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-04-09 | 2026-04-13 | 7,072 | $73.64 | $520.8K | 4,431,375 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-04-09 | 2026-04-13 | 5,128 | $74.57 | $382.4K | 4,426,247 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-04-09 | 2026-04-13 | 7,800 | $75.53 | $589.1K | 4,418,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-04-09 | 2026-04-13 | 7,200 | $73.64 | $530.2K | 628,486 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | A Award deriv | 2026-03-27 | 2026-03-31 | 33,417 | — | $0 | 33,417 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2026-03-17 | 2026-03-19 | 40,570 | — | $0 | 40,570 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2026-03-17 | 2026-03-19 | 104,313 | — | $0 | 104,313 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-13 | 2026-03-16 | 10,241 | $68.39 | $700.4K | 4,448,206 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-13 | 2026-03-16 | 10,310 | $69.20 | $713.5K | 635,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-13 | 2026-03-16 | 9,690 | $68.36 | $662.4K | 645,996 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-13 | 2026-03-16 | 9,759 | $69.23 | $675.6K | 4,438,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-12 | 2026-03-16 | 13,885 | $68.47 | $950.7K | 4,464,562 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-12 | 2026-03-16 | 14,337 | $68.48 | $981.8K | 661,349 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-12 | 2026-03-16 | 5,363 | $69.32 | $371.8K | 655,986 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-12 | 2026-03-16 | 300 | $70.15 | $21.0K | 4,458,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-12 | 2026-03-16 | 5,815 | $69.29 | $402.9K | 4,458,747 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-03-12 | 2026-03-16 | 300 | $70.15 | $21.0K | 655,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-19 | 2026-02-23 | 602 | $72.80 | $43.8K | 234,451 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-19 | 2026-02-23 | 8,528 | $72.08 | $614.7K | 235,053 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-19 | 2026-02-23 | 18,923 | $71.03 | $1.34M | 243,581 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-02-16 | 2026-02-18 | 33,544 | — | $0 | 134,176 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-02-16 | 2026-02-18 | 19,600 | — | $0 | 156,794 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-02-16 | 2026-02-18 | 11,554 | — | $0 | 138,645 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2026-02-16 | 2026-02-18 | 30,970 | $75.25 | $2.33M | 262,504 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-02-16 | 2026-02-18 | 33,544 | — | $0 | 262,320 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-02-16 | 2026-02-18 | 19,600 | — | $0 | 281,920 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-02-16 | 2026-02-18 | 11,554 | — | $0 | 293,474 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 3,716 | $71.44 | $265.5K | 684,164 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 7,806 | $70.69 | $551.8K | 687,880 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 4,484 | $72.64 | $325.7K | 679,680 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 3,775 | $71.46 | $269.8K | 4,486,812 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 4,404 | $72.65 | $320.0K | 4,482,408 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 3,961 | $73.25 | $290.1K | 4,478,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 3,994 | $73.25 | $292.6K | 675,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-11 | 2026-02-12 | 7,860 | $70.70 | $555.7K | 4,490,587 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-10 | 2026-02-12 | 14,201 | $71.80 | $1.02M | 701,485 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-10 | 2026-02-12 | 5,960 | $72.27 | $430.7K | 4,498,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-10 | 2026-02-12 | 14,040 | $71.80 | $1.01M | 4,504,407 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-10 | 2026-02-12 | 5,799 | $72.28 | $419.2K | 695,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 6,955 | $76.72 | $533.6K | 726,580 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 10,519 | $77.61 | $816.4K | 716,061 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 375 | $78.19 | $29.3K | 715,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 1,401 | $75.61 | $105.9K | 4,537,046 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 6,067 | $76.53 | $464.3K | 4,530,979 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 10,677 | $77.46 | $827.0K | 4,520,302 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 1,855 | $78.10 | $144.9K | 4,518,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 2,151 | $75.75 | $162.9K | 733,535 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 8,135 | $74.38 | $605.1K | 4,538,747 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 11,565 | $73.65 | $851.8K | 4,546,882 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 300 | $75.20 | $22.6K | 4,538,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 8,085 | $74.38 | $601.4K | 736,086 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 400 | $75.16 | $30.1K | 735,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 11,515 | $73.64 | $848.0K | 744,171 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-15 | 2025-12-16 | 28,311 | $74.60 | $2.11M | 230,476 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-15 | 2025-12-16 | 1,700 | $75.24 | $127.9K | 228,776 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-12-12 | 2025-12-16 | 60,975 | — | $0 | 60,976 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2025-12-12 | 2025-12-16 | 30,964 | $75.15 | $2.33M | 258,787 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-12-12 | 2025-12-16 | 60,975 | — | $0 | 289,751 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-05 | 2025-12-08 | 7,483 | $73.76 | $551.9K | 755,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-05 | 2025-12-08 | 12,288 | $73.04 | $897.5K | 4,566,159 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-05 | 2025-12-08 | 7,712 | $73.75 | $568.8K | 4,558,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-05 | 2025-12-08 | 12,517 | $73.05 | $914.4K | 763,169 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-04 | 2025-12-08 | 5,700 | $74.80 | $426.4K | 4,578,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-04 | 2025-12-08 | 12,200 | $74.42 | $907.9K | 4,584,147 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-04 | 2025-12-08 | 2,100 | $73.16 | $153.6K | 4,596,347 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-04 | 2025-12-08 | 5,708 | $74.80 | $427.0K | 775,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-04 | 2025-12-08 | 12,192 | $74.42 | $907.3K | 781,394 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-12-04 | 2025-12-08 | 2,100 | $73.16 | $153.6K | 793,586 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 14,299 | $65.90 | $942.3K | 234,232 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 5,456 | $66.71 | $364.0K | 228,776 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 6,401 | $64.97 | $415.9K | 248,531 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-11-16 | 2025-11-18 | 19,599 | — | $0 | 176,394 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-11-16 | 2025-11-18 | 11,554 | — | $0 | 150,199 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-11-16 | 2025-11-18 | 33,544 | — | $0 | 167,720 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-11-16 | 2025-11-18 | 19,599 | — | $0 | 276,233 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-11-16 | 2025-11-18 | 11,554 | — | $0 | 287,787 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2025-11-16 | 2025-11-18 | 32,855 | $66.39 | $2.18M | 254,932 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-11-16 | 2025-11-18 | 33,544 | — | $0 | 256,634 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 220 | $62.79 | $13.8K | 795,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 7,546 | $61.87 | $466.9K | 795,906 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 12,234 | $61.13 | $747.9K | 803,452 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 200 | $62.81 | $12.6K | 4,598,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 7,308 | $61.87 | $452.1K | 4,598,647 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-07 | 2025-11-10 | 12,492 | $61.14 | $763.8K | 4,605,955 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 7,324 | $63.55 | $465.4K | 4,618,547 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 12,576 | $62.91 | $791.2K | 4,625,871 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 100 | $64.39 | $6.4K | 815,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 7,371 | $63.56 | $468.5K | 815,786 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 12,529 | $62.91 | $788.2K | 823,157 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-06 | 2025-11-10 | 100 | $64.39 | $6.4K | 4,618,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-09 | 2025-10-10 | 20,000 | $54.80 | $1.10M | 4,638,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-09 | 2025-10-10 | 20,000 | $54.80 | $1.10M | 835,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-08 | 2025-10-10 | 11,294 | $55.09 | $622.2K | 4,658,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-08 | 2025-10-10 | 8,705 | $54.39 | $473.5K | 866,981 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-08 | 2025-10-10 | 11,295 | $55.09 | $622.2K | 855,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-08 | 2025-10-10 | 8,706 | $54.39 | $473.5K | 4,669,741 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 16,800 | $53.16 | $893.1K | 4,679,347 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 2,300 | $51.95 | $119.5K | 4,696,147 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 16,900 | $53.16 | $898.4K | 876,486 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 900 | $53.80 | $48.4K | 4,678,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 2,300 | $51.96 | $119.5K | 893,386 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 800 | $53.80 | $43.0K | 875,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-04 | 2025-09-08 | 5,475 | $51.85 | $283.9K | 4,698,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-04 | 2025-09-08 | 14,525 | $51.15 | $743.0K | 4,703,922 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-04 | 2025-09-08 | 5,442 | $51.85 | $282.2K | 895,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-04 | 2025-09-08 | 14,558 | $51.16 | $744.8K | 901,128 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-20 | 2025-08-22 | 25,728 | $48.81 | $1.26M | 223,518 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-20 | 2025-08-22 | 428 | $49.25 | $21.1K | 223,090 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-08-16 | 2025-08-19 | 11,554 | — | $0 | 161,753 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-08-16 | 2025-08-19 | 33,544 | — | $0 | 201,264 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-08-16 | 2025-08-19 | 19,599 | — | $0 | 195,993 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2025-08-16 | 2025-08-19 | 32,855 | $51.32 | $1.69M | 249,246 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-08-16 | 2025-08-19 | 64,697 | — | $0 | 282,101 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-08 | 2025-08-11 | 11,795 | $45.88 | $541.2K | 4,726,652 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-08 | 2025-08-11 | 8,205 | $46.71 | $383.3K | 4,718,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-08 | 2025-08-11 | 11,795 | $45.88 | $541.2K | 923,891 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-08 | 2025-08-11 | 8,205 | $46.71 | $383.3K | 915,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-07 | 2025-08-11 | 6,784 | $45.09 | $305.9K | 4,751,663 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-07 | 2025-08-11 | 13,216 | $45.64 | $603.2K | 4,738,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-07 | 2025-08-11 | 6,784 | $45.09 | $305.9K | 948,902 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-08-07 | 2025-08-11 | 13,216 | $45.64 | $603.2K | 935,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-07-02 | 2025-07-03 | 20,000 | $42.73 | $854.6K | 4,758,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-07-02 | 2025-07-03 | 20,000 | $42.73 | $854.6K | 955,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-03 | 18,400 | $42.51 | $782.2K | 977,286 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-03 | 1,700 | $42.88 | $72.9K | 4,778,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-03 | 18,300 | $42.50 | $777.8K | 4,780,147 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-03 | 1,600 | $42.89 | $68.6K | 975,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-05-20 | 2025-05-20 | 75,000 | $33.40 | $2.50M | 4,798,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-05-19 | 2025-05-20 | 25,756 | $33.32 | $858.2K | 217,804 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-05-19 | 2025-05-20 | 400 | $33.75 | $13.5K | 217,404 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-05-16 | 2025-05-20 | 11,553 | — | $0 | 173,307 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-05-16 | 2025-05-20 | 19,599 | — | $0 | 215,592 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-05-16 | 2025-05-20 | 33,544 | — | $0 | 234,808 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2025-05-16 | 2025-05-20 | 32,854 | $33.84 | $1.11M | 243,560 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-05-16 | 2025-05-20 | 64,696 | — | $0 | 276,414 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-04-22 | 2025-04-24 | 75,000 | $34.11 | $2.56M | 4,873,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-03-25 | 2025-03-27 | 75,000 | $36.87 | $2.77M | 4,948,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2025-03-19 | 2025-03-21 | 184,860 | — | $0 | 184,860 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2025-03-19 | 2025-03-21 | 71,208 | — | $0 | 71,208 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-02-25 | 2025-02-27 | 37,899 | $33.36 | $1.26M | 5,060,548 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-02-25 | 2025-02-27 | 37,101 | $33.79 | $1.25M | 5,023,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-02-19 | 2025-02-19 | 76 | $36.56 | $2.8K | 211,718 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-02-19 | 2025-02-19 | 31,467 | $36.14 | $1.14M | 211,794 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 33,544 | — | $0 | 268,352 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 19,600 | — | $0 | 235,191 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 2,395 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2025-02-16 | 2025-02-19 | 23,996 | $34.90 | $837.5K | 243,261 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-02-16 | 2025-02-19 | 55,539 | — | $0 | 267,257 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-01-29 | 2025-01-30 | 269,068 | $36.34 | $9.78M | 5,102,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-01-29 | 2025-01-30 | 4,000 | $36.82 | $147.3K | 5,098,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-01-28 | 2025-01-30 | 326,932 | $36.29 | $11.86M | 5,371,515 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | G Gift | 2024-12-24 | 2024-12-27 | 4,685,725 | — | $0 | 5,698,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | G Gift | 2024-12-24 | 2024-12-27 | 4,685,725 | — | $0 | 211,718 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-12-10 | 2024-12-12 | 121,951 | — | $0 | 121,951 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-11-19 | 2024-11-20 | 1,875 | $22.76 | $42.7K | 4,897,443 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-11-19 | 2024-11-20 | 25,514 | $22.39 | $571.3K | 4,899,318 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-11-16 | 2024-11-19 | 2,394 | — | $0 | 2,395 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-11-16 | 2024-11-19 | 33,544 | — | $0 | 301,896 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-11-16 | 2024-11-19 | 19,599 | — | $0 | 254,791 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-11-16 | 2024-11-19 | 28,148 | $23.72 | $667.7K | 4,924,832 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-11-16 | 2024-11-19 | 55,537 | — | $0 | 4,952,980 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-08-19 | 2024-08-20 | 11,197 | $25.13 | $281.4K | 4,897,443 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-08-19 | 2024-08-20 | 16,192 | $24.39 | $394.9K | 4,897,443 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-20 | 2,394 | — | $0 | 4,789 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-20 | 19,599 | — | $0 | 274,390 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-20 | 33,544 | — | $0 | 335,440 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-08-16 | 2024-08-20 | 28,148 | $24.40 | $686.8K | 4,924,832 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-08-16 | 2024-08-20 | 55,537 | — | $0 | 4,952,980 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 2,394 | — | $0 | 7,183 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 33,544 | — | $0 | 368,984 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 19,599 | — | $0 | 293,989 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-05-16 | 2024-05-17 | 5,130 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-05-16 | 2024-05-17 | 30,748 | $31.04 | $954.4K | 4,897,443 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-05-16 | 2024-05-17 | 60,667 | — | $0 | 4,928,191 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-03-12 | 2024-03-14 | 45,140 | — | $0 | 45,140 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-03-12 | 2024-03-14 | 313,588 | — | $0 | 313,588 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 5,129 | — | $0 | 5,130 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 33,544 | — | $0 | 402,528 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 61,182 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2024-02-16 | 2024-02-21 | 2,394 | — | $0 | 9,577 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2024-02-16 | 2024-02-21 | 102,249 | — | $0 | 4,915,446 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2024-02-16 | 2024-02-21 | 47,922 | $37.21 | $1.78M | 4,867,524 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 51,352 | $29.10 | $1.49M | 4,813,397 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 200 | $29.55 | $5.9K | 4,813,197 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 61,182 | — | $0 | 61,182 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 2,394 | — | $0 | 11,971 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 33,544 | — | $0 | 436,072 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-11-16 | 2023-11-20 | 5,129 | — | $0 | 10,259 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-11-16 | 2023-11-20 | 50,697 | $28.86 | $1.46M | 4,864,749 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-11-16 | 2023-11-20 | 102,249 | — | $0 | 4,915,446 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-08-17 | 2023-08-18 | 51,552 | $28.59 | $1.47M | 4,813,197 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 5,130 | — | $0 | 15,388 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 33,544 | — | $0 | 469,616 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 61,182 | — | $0 | 122,364 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 2,394 | — | $0 | 14,365 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-08-16 | 2023-08-18 | 50,698 | $29.80 | $1.51M | 4,864,749 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-08-16 | 2023-08-18 | 102,250 | — | $0 | 4,915,447 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-05-17 | 2023-05-18 | 51,552 | $14.01 | $722.2K | 4,813,197 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 33,544 | — | $0 | 503,160 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 61,182 | — | $0 | 183,546 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 2,394 | — | $0 | 16,759 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 5,129 | — | $0 | 20,518 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-05-16 | 2023-05-18 | 50,697 | $14.09 | $714.3K | 4,864,749 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-05-16 | 2023-05-18 | 102,249 | — | $0 | 4,915,446 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-05-03 | 2023-05-05 | 120,000 | $14.18 | $1.70M | 1,012,722 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-04-05 | 2023-04-07 | 120,000 | $15.46 | $1.86M | 1,132,722 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-03-03 | 2023-03-03 | 120,000 | $10.96 | $1.32M | 1,252,722 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-02-17 | 2023-02-21 | 44,798 | $12.70 | $568.9K | 4,813,197 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 5,129 | — | $0 | 25,647 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 2,395 | — | $0 | 19,153 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 61,182 | — | $0 | 244,728 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2023-02-16 | 2023-02-21 | 68,706 | — | $0 | 4,881,903 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | F Tax w/h | 2023-02-16 | 2023-02-21 | 23,908 | $12.64 | $302.2K | 4,857,995 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-02-10 | 2023-02-14 | 536,704 | — | $0 | 536,704 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-02-10 | 2023-02-14 | 624,652 | — | $0 | 624,652 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-02-03 | 2023-02-06 | 120,000 | $11.01 | $1.32M | 1,372,722 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-01-05 | 2023-01-06 | 120,000 | $7.67 | $920.4K | 1,492,722 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 200,000 | — | $0 | 995,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 34,640 | $9.40 | $325.6K | 4,813,197 | SEC↗ |